Tail vein injections of pimonidazole HypoxyprobeTM (HPI, Inc.)into tumour-bearing WT, Cldn14-het and Cldn14-null mice showed that the relative levels of tumour hypoxia were similar between WT and Cldn14-null mice (Figure 2C, D). This evidence concerns the gene CLDN14 and neoplasm.